000028 國藥一致
按盤價 
27.010 +0.590 (+2.233%)
27.010 +0.590 (+2.233%) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 6.262 | 3.663 | 9.536 | 9.576 | 9.257 |
| 總資產報酬率 ROA (%) | 2.351 | 1.351 | 3.547 | 3.482 | 3.245 |
| 投入資產回報率 ROIC (%) | 3.431 | 1.993 | 5.331 | 5.305 | 4.891 | 邊際利潤分析 |
| 銷售毛利率 (%) | 10.680 | 11.091 | 11.993 | 12.154 | 11.730 |
| 營業利潤率 (%) | 2.061 | 0.771 | 3.269 | 3.140 | 2.856 |
| 息稅前利潤/營業總收入 (%) | 2.305 | 1.096 | 3.548 | 3.405 | 3.200 |
| 淨利潤/營業總收入 (%) | 1.537 | 0.319 | 2.595 | 2.412 | 2.235 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 106.230 | 236.506 | 88.968 | 92.314 | 93.073 |
| 價值變動淨收益/利潤總額(%) | 14.628 | 38.424 | 8.971 | 7.269 | 14.805 |
| 營業外收支淨額/利潤總額(%) | -0.252 | 0.346 | 0.235 | 0.216 | 1.136 | 償債能力分析 |
| 流動比率 (X) | 1.540 | 1.515 | 1.494 | 1.508 | 1.423 |
| 速動比率 (X) | 1.229 | 1.216 | 1.166 | 1.135 | 1.083 |
| 資產負債率 (%) | 55.955 | 56.356 | 55.902 | 54.372 | 57.876 |
| 帶息債務/全部投入資本 (%) | 40.853 | 39.358 | 38.617 | 34.713 | 38.643 |
| 股東權益/帶息債務 (%) | 134.875 | 138.425 | 140.732 | 166.172 | 137.493 |
| 股東權益/負債合計 (%) | 67.742 | 65.930 | 65.486 | 69.595 | 60.275 |
| 利息保障倍數 (X) | 9.248 | 3.404 | 13.092 | 13.195 | 10.294 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 100.315 | 90.842 | 76.136 | 72.863 | 78.376 |
| 存貨周轉天數 (天) | 42.622 | 41.905 | 42.883 | 43.126 | 41.485 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 02/04/2026 14:32 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
